MENDICINO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 110
AS - Asia 94
EU - Europa 65
SA - Sud America 10
OC - Oceania 2
Totale 281
Nazione #
US - Stati Uniti d'America 105
SG - Singapore 51
IT - Italia 38
CN - Cina 15
VN - Vietnam 12
BR - Brasile 9
IN - India 9
GB - Regno Unito 8
DE - Germania 6
FI - Finlandia 4
PL - Polonia 4
HK - Hong Kong 3
CA - Canada 2
MX - Messico 2
NZ - Nuova Zelanda 2
AR - Argentina 1
BD - Bangladesh 1
CR - Costa Rica 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
MD - Moldavia 1
NL - Olanda 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SE - Svezia 1
Totale 281
Città #
Singapore 26
Ashburn 15
Dallas 12
San Jose 12
Chandler 8
Hefei 8
Santa Clara 8
Bengaluru 7
Ho Chi Minh City 6
Chicago 5
London 5
Munich 5
Catanzaro 4
Milan 4
Beijing 3
Boardman 3
Pistoia 3
Auckland 2
Chennai 2
Helsinki 2
Hong Kong 2
Lawrence 2
Los Angeles 2
Princeton 2
Rome 2
Rozzano 2
Turku 2
Warsaw 2
Acri 1
Amsterdam 1
Baependi 1
Biên Hòa 1
Bom Despacho 1
Bom Repouso 1
Bowmanville 1
Bragança Paulista 1
Brooklyn 1
Centro Municipality 1
Chacabuco 1
Chisinau 1
Clarksburg 1
Da Nang 1
Denver 1
Des Moines 1
Florence 1
Haiphong 1
Hanoi 1
Hanover 1
Kizlyar 1
Liberia 1
Mexico City 1
Milwaukee 1
Minneapolis 1
Montreal 1
Rangpur City 1
Riyadh 1
San Francisco 1
Santo André 1
Seattle 1
São Gonçalo 1
São Paulo 1
Tibagi 1
Tokyo 1
Turin 1
Vitória de Santo Antão 1
Totale 193
Nome #
COVID-19: high-JAKing of the inflammatory “flight” by ruxolitinib to avoid the cytokine storm 82
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 43
Belantamab mafodotin in multiple myeloma 41
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 39
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 35
Elotuzumab in multiple myeloma 28
Isatuximab in multiple myeloma 23
Totale 291
Categoria #
all - tutte 2.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 9 0 2 0 5 0
2021/202215 0 2 0 1 0 7 1 1 0 0 3 0
2022/202326 5 2 1 1 1 2 4 3 3 2 2 0
2023/202441 5 8 4 8 3 9 0 0 0 0 1 3
2024/202570 7 2 1 2 4 10 0 0 12 1 14 17
2025/2026113 14 20 16 11 21 12 19 0 0 0 0 0
Totale 291